PenRad’s High-Risk Breast Clinic module offers a comprehensive solution for patients and clinicians. Automated breast cancer risk assessment, genetic testing eligibility, insurance authorization, patient education, data management and more, are all included in this offering.
PenRad’s High-Risk Breast Clinic module improves client and patient satisfaction and can increase client revenue. This module automatically computes breast cancer risk values by factoring in breast density and the seven types of patient and relatives’ cancer incidence, plus BRCA findings. Genetic testing is the ultimate risk identifier, factoring in multiple cancer types for patients and their relatives
Leveraging the Tyrer Cuzick algorithm, this module automatically references a patient’s breast density, patient and familial breast and ovarian cancer history and BRCA findings to calculate the breast cancer risk value.
PenRad’s products are supported by PenCare, a proactive and dedicated support platform committed to customer service. PenCare can provide: software platform enhancements, regulatory updates, industry information, software training, patient needs support, structured report generation, letter template support and more.